A5069162638- Bladder and Urothelial Cancer Treatments
- Prostate Cancer Diagnosis and Treatment
- Urological Disorders and Treatments
- Urinary and Genital Oncology Studies
- Prostate Cancer Treatment and Research
- Renal cell carcinoma treatment
- Cancer Immunotherapy and Biomarkers
- Urologic and reproductive health conditions
- Immune cells in cancer
- Nutrition and Health in Aging
- Ureteral procedures and complications
- Renal and related cancers
- Venous Thromboembolism Diagnosis and Management
- Surgical Simulation and Training
- Pancreatic and Hepatic Oncology Research
- Immunotherapy and Immune Responses
- Frailty in Older Adults
- Cancer, Lipids, and Metabolism
- Renal and Vascular Pathologies
- Multiple and Secondary Primary Cancers
- Pediatric Urology and Nephrology Studies
- Pelvic floor disorders treatments
- Colorectal Cancer Surgical Treatments
- Colorectal Cancer Screening and Detection
- Sexual function and dysfunction studies
Mayo Clinic
2016-2025
WinnMed
2013-2025
Mayo Clinic in Arizona
2015-2024
Mayo Clinic in Florida
2013-2024
Evidence (Italy)
2023
Michigan Department of Education
2023
American Urological Association
2023
National Hospital
2022
The University of Texas Southwestern Medical Center
2022
Harold C. Simmons Comprehensive Cancer Center
2022
Through a comprehensive review of the Mayo Clinic experience with patients who had Meckel diverticulum, we sought to determine which diverticula should be removed when discovered incidentally during abdominal surgery.Meckel occur so infrequently that most articles have reported either small series or isolated cases. From these limited series, various conclusions been without clearly indicating incidental removed.Medical records were reviewed 1476 found diverticulum surgery from 1950 2002....
BACKGROUND The authors evaluated sarcopenia as a predictor of cancer‐specific survival (CSS) and overall (OS) among patients with urothelial cancer the bladder undergoing radical cystectomy (RC). METHODS lumbar skeletal muscle index (SMI) 205 treated RC for between 2000 2007 was measured. Sarcopenia classified according to international consensus definitions (SMI < 55 cm 2 /m men 39 women). CSS OS were estimated using Kaplan‐Meier method compared log‐rank test. Variables associated...
The NCCN Guidelines for Bladder Cancer provide recommendations the diagnosis, evaluation, treatment, and follow-up of patients with bladder cancer other urinary tract cancers (upper tumors, urothelial carcinoma prostate, primary urethra). These Insights summarize panel discussion behind recent important updates to guidelines regarding treatment non–muscle-invasive cancer, including how treat in event a bacillus Calmette-Guérin (BCG) shortage; new roles immune checkpoint inhibitors non–muscle...
Bladder cancer, the sixth most common cancer in United States, is commonly of urothelial carcinoma histologic subtype. The clinical spectrum bladder divided into 3 categories that differ prognosis, management, and therapeutic aims: (1) non-muscle-invasive (NMIBC); (2) muscle invasive, nonmetastatic disease; (3) metastatic cancer. These NCCN Guidelines Insights detail recent updates to for Cancer, including changes fifth edition WHO Classification Tumours: Urinary Male Genital Tumours how...
No AccessJournal of UrologyAdult Urology1 Feb 2011Long-Term Complications Conduit Urinary Diversion Mark S. Shimko, Matthew K. Tollefson, Eric C. Umbreit, Sara A. Farmer, Michael L. Blute, and Igor Frank ShimkoMark Shimko Department Urology, Mayo Medical School Clinic, Rochester, Minnesota , TollefsonMatthew Tollefson UmbreitEric Umbreit FarmerSara Farmer Health Sciences Research, BluteMichael Blute FrankIgor View All Author Informationhttps://doi.org/10.1016/j.juro.2010.09.096AboutFull...
We evaluate the association between severe skeletal muscle deficiency or sarcopenia, and disease progression, cancer specific mortality all cause in patients with localized renal cell carcinoma treated radical nephrectomy.The baseline lumbar index of 387 nephrectomy for nonmetastatic 2000 2010 was measured on preoperative computerized tomography. Sarcopenia classified according to gender consensus definitions as male-skeletal less than 55 cm(2)/m(2) female-skeletal 39 cm(2)/m(2)....
No AccessJournal of UrologyAdult Urology1 Mar 2014Long-Term Renal Function Outcomes after Radical Cystectomy Manuel S. Eisenberg, R. Houston Thompson, Igor Frank, Simon P. Kim, Katherine J. Cotter, Matthew K. Tollefson, Dharam Kaushik, Prabin Thapa, Robert Tarrell, and Stephen A. Boorjian EisenbergManuel Eisenberg Department Urology, Mayo Clinic, Rochester, Minnesota , ThompsonR. Thompson FrankIgor Frank KimSimon Kim Yale University, New Haven, Connecticut CotterKatherine Cotter University...
Radical cystectomy continues to be associated with a nonnegligible risk of perioperative death and all cause mortality in the years after surgery remains relatively high. We investigated comparative ability various comorbidity indices predict 5-year radical cystectomy.We evaluated 891 patients who underwent between 1994 2005. The associations American Society Anesthesiologists (ASA) score, Charlson index, Elixhauser index ECOG (Eastern Cooperative Oncology Group) performance status outcomes...
You have accessJournal of UrologyOriginal Research Articles1 Apr 2024Automated Identification Key Steps in Robotic-Assisted Radical Prostatectomy Using Artificial IntelligenceThis article is commented on by the following:Editorial Comment Abhinav Khanna, Alenka Antolin, Omri Bar, Danielle Ben-Ayoun, Maya Zohar, Stephen A. Boorjian, Igor Frank, Paras Shah, Vidit Sharma, R. Houston Thompson, Tamir Wolf, Dotan Asselmann, and Matthew Tollefson KhannaAbhinav Khanna *Corresponding Author: MD, 200...
No AccessJournal of UrologyAdult Urology1 Jun 2012The Implications Hospital Acquired Adverse Events on Mortality, Length Stay and Costs for Patients Undergoing Radical Cystectomy Bladder Cancer Simon P. Kim, Nilay D. Shah, R. Jeffrey Karnes, Christopher J. Weight, Igor Frank, James Moriarty, Leona C. Han, Bijan Borah, Matthew K. Tollefson, Stephen A. Boorjian KimSimon Kim Department Urology, Mayo Clinic, Rochester, Minnesota Nothing to disclose. More articles by this author , ShahNilay Shah...
No AccessJournal of UrologyAdult Urology1 May 2015Mortality after Radical Cystectomy: Impact Obesity Versus Adiposity Adjusting for Skeletal Muscle Wasting Sarah P. Psutka, Stephen A. Boorjian, Michael R. Moynagh, Grant D. Schmit, Igor Frank, Alonso Carrasco, Suzanne B. Stewart, Robert Tarrell, Prabin Thapa, and Matthew K. Tollefson PsutkaSarah Psutka Department Urology, Mayo Clinic, Rochester, Minnesota More articles by this author , BoorjianStephen Boorjian MoynaghMichael Moynagh...
Multiple definitions of biochemical recurrence for prostate cancer exist after radical prostatectomy, and variation continues in outcome reporting secondary treatment initiation. We reviewed long-term prostatectomy outcomes to assess the most appropriate specific antigen cut point that predicts future disease progression.We identified 13,512 patients with cT1-2N0M0 who underwent between 1987 2010. Single points 0.2, 0.3, 0.4 0.5 ng/ml or greater, as well confirmatory value 0.2 greater...
Robot-assisted radical prostatectomy has undergone rapid dissemination driven in part by market forces to become the most frequently used surgical approach management of prostate cancer. Accordingly, a critical analysis its volume-outcome relationship important health policy implications. Therefore, we evaluated association hospital robot-assisted volume with perioperative outcomes, and examined distribution procedure contextualize relationship.We identified 140,671 men who underwent from...